Genomic Profiling Reveals the Potential Role of TCL1A and MDR1 Deficiency in Chemotherapy-Induced Cardiotoxicity
Open Access
- 1 January 2013
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 9 (4) , 350-360
Abstract
Background: Anthracyclines, such as doxorubicin (Adriamycin), are highly effective chemotherapeutic agents, but are well known to cause myocardial dysfunction and life-threatening congestive heart failure (CHF) in some patients.Keywords
This publication has 54 references indexed in Scilit:
- Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cellsBMC Medicine, 2011
- Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic PatientsAnnals of Internal Medicine, 2010
- Expression Profiling of PBMC-based Diagnostic Gene Markers Isolated from Vasculitis PatientsDNA Research, 2008
- Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular EventsCirculation, 2006
- Herceptin and the Heart — A Molecular Modifier of Cardiac FailureNew England Journal of Medicine, 2006
- Expressed genome molecular signatures of heart failureClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Doxorubicin-Induced CardiomyopathyNew England Journal of Medicine, 1998
- Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling PressuresJACC, 1997
- Anthracycline-Induced CardiotoxicityAnnals of Internal Medicine, 1996